Cardiac potassium channel (null)

Cardiac potassium channels are a diverse group of membrane-spanning proteins that mediate the transport of potassium ions across cardiac myocyte membranes. These channels critically shape the cardiac action potential by controlling the phases of repolarization and maintaining resting membrane potential. Distinct subtypes (e.g., hERG/KCNH2, KCNQ1, Kv1.5, Kir2.1) are differentially expressed across heart regions and participate in various currents (I_Kr, I_Ks, I_K1, Ito, IK_ACh, etc.). Drugs targeting these channels play a vital role in antiarrhythmic therapy, but nonspecific blockade carries a significant risk of dangerous ventricular arrhythmias, especially torsades de pointes. The nomenclature "cardiac potassium channel" is generic; precise characterization should specify the relevant subtype due to the molecular and functional heterogeneity among family members. The queried target is overly broad for structured biomedical use. For clinical or research applications, always specify the channel subtype (e.g., "Potassium voltage-gated channel subfamily H member 2" for hERG) as each has distinct pharmacology, physiology, and disease associations.

Other names

Cardiac K⁺ channelCardiac potassium ion channelSpecific subtypes: hERG (KCNH2), KCNQ1, Kv1.5, Kir2.1, etc.

Channel blockade (class III antiarrhythmic agents block K⁺ channels, prolonging repolarization); Channel activation (some, like C28, enhance specific channel activity)